The enduring success of sildenafil has undeniably shaped the drug landscape. However, wagering in companies heavily focused on biosimilars and the declining patent exclusivity surrounding this flagship https://privatebookmark.com/story21379063/the-blue-pill-and-pharmaceutical-companies-a-speculative-venture